News
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Aspire Biopharma Holdings, Inc., Announces First Patient Dosed in Phase 1 Clinical Trial for its Lead Program, an Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation
Aspire Biopharma initiates Phase 1 trial for high-dose aspirin formulation in the United States, targeting accelerated approval with positive data anticipated in 3Q 2025 -
-
COMMUNIQUÉ DE PRESSE
Grid Battery Awards Contract for 2025 Exploration Program on its Copper-Gold Property to Hardline Exploration
Grid Battery Metals Inc. announces exploration program with Hardline Exploration in BC. Focus on Copper-Gold Project in favorable mining region. Preliminary work planned for 2025 summer season -
COMMUNIQUÉ DE PRESSE
SAF-HOLLAND looks back on strong operating performance in a challenging market environment – Annual General Meeting 2025 approves all agenda items
SAF-HOLLAND SE reports strong operating performance in challenging market environment at the Annual General Meeting 2025. Company approves dividend, elects new Supervisory Board members, and outlines 'drive2030' strategy -
